#United States #Tempe #ECU Health #GT Medical Technologies #GammaTile®

GT Medical Technologies Welcomes New GammaTile Center of Excellence Designation

GT Medical Technologies, a pioneering medical device firm committed to enhancing the lives of those affected by brain tumors, has announced a significant step forward in patient care. On December 3, 2025, the organization designated ECU Health as the latest GammaTile® Center of Excellence (COE). This designation acknowledges institutions that demonstrate remarkable proficiency in administering the GammaTile procedure and a commitment to advancing treatment for brain tumor patients.

For leaders in brain tumor care, the GammaTile COE designation serves as a symbol of ongoing excellence. Physicians and hospitals qualified for this recognition must meet stringent clinical criteria, including minimum annual case numbers and a commitment to continuous education and training. This is part of GT Medical Technologies’ broader initiative to ensure that the best possible care is available to brain tumor patients across the healthcare system.

Recognition of Exceptional Physicians
ECU Health’s accomplishment also highlights the individual practitioners who contribute to its success. Notably, the following medical professionals have received accolades for their contributions to the GammaTile program:

• - Christopher Bentley, DABR, Medical Physicist
• - Aaron E. Bond, MD, Neurosurgeon
• - Sean Cavenaugh, MS, DABR, Medical Physicist
• - Richard Dalyai, MD, Neurosurgeon
• - Heather Grillo, Nuclear Medicine Technologist
• - Jennifer L. Griswold, MD, Neurosurgeon
• - Regis G. Hoppenot, MD, Neurosurgeon
• - Blane Jernigan, Medical Physicist
• - Andrew W. Ju, MD, Radiation Oncologist
• - Hilal A. Kanaan, MD, Neurosurgeon
• - K. Stuart Lee, MD, Neurosurgeon
• - M. Sean Peach, MD, Radiation Oncologist
• - David Rushing, MSPH, Medical Physicist
• - Lenwood P. Smith, Jr., MD, Neurosurgeon

Dr. M. Sean Peach from ECU Brody School of Medicine and Director of Brachytherapy at ECU Health emphasized the significance of this designation. He stated, "Receiving designation as a GammaTile Center of Excellence reflects our team's ongoing commitment to advancing brain tumor care for our patients. GammaTile allows us to deliver radiation therapy safely and effectively at the time of surgery, giving patients new hope and better outcomes while preserving healthy brain function."

About GammaTile
The GammaTile employs an innovative approach to delivering radiation therapy. Administratively placed during the surgical removal of a tumor, this bioabsorbable collagen implant is embedded with radioactive seeds, providing targeted radiation therapy right where it is needed most. Unlike traditional methods that delay radiation therapy until after healing has commenced, GammaTile offers immediate treatment when cancer cells remain vulnerable. This innovative approach maximizes the radiation’s effectiveness can significantly lower the chances of tumor regrowth while safeguarding surrounding healthy brain tissue.

Since its introduction to the market in March 2020, GammaTile has been embraced by more than 100 esteemed medical centers, establishing itself as a vital tool in the fight against brain tumors into both academic and community practice settings. GT Medical Technologies was founded by a team of specialists specifically to address gaps in brain tumor treatment, and their commitment is underscored by ongoing advancements in technologies and patient care solutions.

For further details about GammaTile and its revolutionary treatment approach, visit gammatile.com and follow their social media on Facebook, Instagram, LinkedIn, and X for the latest updates.

As brain tumor treatment continues to evolve, designations like the GammaTile Center of Excellence represent essential milestones toward achieving better patient outcomes and advancing medical knowledge in this critical field.